Bellevue Group AG Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001674546

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2026 · 148 positions · Total reported value $4.75B · Top-10 concentration 42.9% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 61.0% · 17 new · 64 cut · 24 exited

Active Share (vs S&P 500): 94.1% · vs QQQ: 96.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $4.20B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, Bellevue Group AG disclosed 148 equity positions with a combined reported value of $4.75B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 42.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were AMGN ($308.36M), VRTX ($287.42M), ARGX ($279.26M). By sector, the heaviest allocations are Health Care 92.6%, Industrials 1.7%. Versus the prior quarter, allocation shifted toward Health Care (+0.7pp) and away from Other (-0.7pp).

Versus the prior quarter, Bellevue Group AG opened 17 new positions, trimmed 64 and fully exited 24, a turnover rate of 61.0% of positions. The portfolio's overlap with the prior quarter was 76% of names.

The largest new positions opened in Q2 2026 were AVLN ($44.44M), CGON ($35.07M), SPTX ($23.89M).

Of the 24 positions fully exited versus the prior quarter, the largest were EWTX ($48.15M), INSP ($5.14M), PEN ($4.03M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • AVLN AVALYN PHARMA INC · $44.44M
  • CGON CG ONCOLOGY INC · $35.07M
  • SPTX SEAPORT THERAPEUTICS INC · $23.89M
  • PVLA PALVELLA THERAPEUTICS INC · $23.69M
  • SYRE SPYRE THERAPEUTICS INC · $20.41M
  • COAG HEMAB THERAPEUTICS HOLDINGS · $20.20M
  • PBLS PARABILIS MEDICINES INC · $13.69M
  • AURA AURA BIOSCIENCES INC · $8.28M

Fully Exited (vs previous quarter)

  • EWTX EDGEWISE THERAPEUTICS INC · prev qtr: $48.15M
  • INSP INSPIRE MED SYS INC COM · prev qtr: $5.14M
  • PEN PENUMBRA INC · prev qtr: $4.03M
  • RNA ATRIUM THERAPEUTICS INC · prev qtr: $3.52M
  • MASI MASIMO CORP · prev qtr: $1.56M
  • EQNR Equinor Asa · prev qtr: $741.58K
  • XOM EXXONMOBIL HOLDINGS CORP · prev qtr: $741.41K
  • BP BP PLC SPONSORED ADR · prev qtr: $735.27K

Insider Transactions (Form 4)

Latest Bellevue Group AG buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Bellevue Group AG files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 148 positions worth $4.75B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 148 positions · $4.75B reported value (Q2 2026)
  • Top 10 holdings = 42.9% of reported value
  • Largest position: AMGN (AMGEN INC) at 6.5%
  • Average position size: $32.11M

Sector Tilt

  • Health Care 92.6%
  • Industrials 1.7%
  • Information Technology 0.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 17 new, 39 added, 64 reduced, 24 exited
  • 28 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 92.6%
Technology 0.4%
Other 4.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 851.55K $308.36M 6.49%
6.49%
Add
2 578.63K $287.42M 6.05%
6.05%
Reduce
3 301.00K $279.26M 5.88%
5.88%
Reduce
4 2.16M $272.74M 5.74%
5.74%
Add
5 1.05M $196.27M 4.13%
4.13%
Reduce
6 1.66M $157.71M 3.32%
3.32%
Add
7 1.39M $148.57M 3.13%
3.13%
Add
8 2.45M $134.73M 2.83%
2.83%
Reduce
9 1.05M $130.08M 2.74%
2.74%
Hold
10 6.73M $123.67M 2.60%
2.60%
Hold
11 6.19M $115.74M 2.44%
2.44%
Reduce
12 1.97M $114.63M 2.41%
2.41%
Add
13 188.51K $102.14M 2.15%
2.15%
Add
14 254.81K $101.33M 2.13%
2.13%
Reduce
15 157.29K $98.08M 2.06%
2.06%
Reduce
16 2.62M $98.04M 2.06%
2.06%
Reduce
17 1.19M $88.59M 1.86%
1.86%
Add
18 2.79M $88.53M 1.86%
1.86%
Hold
19 947.12K $85.94M 1.81%
1.81%
Reduce
20 268.46K $84.52M 1.78%
1.78%
Add
21 994.23K $77.78M 1.64%
1.64%
Add
22 972.26K $77.09M 1.62%
1.62%
Reduce
23 1.49M $75.62M 1.59%
1.59%
Reduce
24 1.71M $73.41M 1.54%
1.54%
Hold
25 3.06M $67.95M 1.43%
1.43%
Reduce
26 739.23K $66.87M 1.41%
1.41%
Reduce
27 1.98M $66.20M 1.39%
1.39%
Reduce
28 149.13K $61.98M 1.30%
1.30%
Add
29 822.49K $55.39M 1.17%
1.17%
Add
30 1.20M $44.65M 0.94%
0.94%
Hold
31 1.35M $44.44M 0.94%
0.94%
New
32 1.62M $42.11M 0.89%
0.89%
Reduce
33 560.00K $40.96M 0.86%
0.86%
Add
34 79.82K $40.02M 0.84%
0.84%
Add
35 887.65K $37.88M 0.80%
0.80%
Reduce
36 29.88K $35.84M 0.75%
0.75%
Reduce
37 493.60K $35.07M 0.74%
0.74%
New
38 61.78K $32.52M 0.68%
0.68%
Reduce
39 148.19K $28.88M 0.61%
0.61%
Reduce
40 77.53K $28.82M 0.61%
0.61%
Reduce
41 1.19M $28.80M 0.61%
0.61%
Reduce
42 143.84K $27.40M 0.58%
0.58%
Reduce
43 103.28K $26.23M 0.55%
0.55%
Reduce
44 1.10M $23.89M 0.50%
0.50%
New
45 155.00K $23.69M 0.50%
0.50%
New
46 139.68K $23.56M 0.50%
0.50%
Hold
47 4.10M $23.41M 0.49%
0.49%
Reduce
48 58.40K $23.20M 0.49%
0.49%
Reduce
49 56.45K $21.83M 0.46%
0.46%
Add
50 694.18K $21.70M 0.46%
0.46%
Reduce

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 60% R 60% F1 60% (modelled on 2026-Q1; 6/10 hit)

Historical Backtest (10 quarters)

Avg precision 83% · recall 83% · F1 83% · avg rank error 2.0 · Top-10 turnover 16%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 80% 80% 80% IONS · ARGX · NBIX · ISRG · VRTX · ITCI · MRNA · BSX · ALNY · ABT IONS · ARGX · NBIX · VRTX · ISRG · BSX · ITCI · MRNA · DXCM · RVMD
2024-Q2 80% 80% 80% IONS · ARGX · NBIX · ISRG · VRTX · BSX · ITCI · MRNA · DXCM · RVMD IONS · ARGX · VRTX · NBIX · ISRG · ALNY · BSX · RVMD · SYK · MRNA
2024-Q3 90% 90% 90% IONS · ARGX · VRTX · NBIX · ISRG · ALNY · RVMD · BSX · SYK · MRNA ARGX · IONS · VRTX · ISRG · ALNY · RVMD · NBIX · BSX · ABT · SYK
2024-Q4 90% 90% 90% ARGX · IONS · VRTX · ISRG · RVMD · ALNY · NBIX · ABT · BSX · SYK ARGX · IONS · NBIX · ISRG · ITCI · VRTX · RVMD · ABT · BSX · SYK
2025-Q1 90% 90% 90% ARGX · IONS · NBIX · ISRG · ITCI · ABT · VRTX · RVMD · BSX · SYK ARGX · IONS · SYK · ISRG · ALNY · ABT · NBIX · VRTX · BSX · RVMD
2025-Q2 100% 100% 100% ARGX · IONS · SYK · ALNY · ISRG · ABT · NBIX · VRTX · BSX · RVMD ARGX · IONS · NBIX · ALNY · ABT · SYK · ISRG · VRTX · BSX · RVMD
2025-Q3 100% 100% 100% ARGX · IONS · NBIX · ALNY · SYK · ABT · ISRG · VRTX · BSX · RVMD IONS · ARGX · RVMD · NBIX · ALNY · VRTX · ABT · SYK · BSX · ISRG
2025-Q4 80% 80% 80% ARGX · IONS · RVMD · NBIX · VRTX · ABT · ALNY · SYK · BSX · ISRG RVMD · ARGX · IONS · VRTX · NBIX · RNAM · ISRG · SRRK · ALNY · ABT
2026-Q1 60% 60% 60% RVMD · ARGX · IONS · VRTX · NBIX · RNAM · SRRK · ISRG · ALNY · ABT VRTX · ARGX · REGN · SRRK · GILD · RVMD · IONS · ISRG · VRDN · KRYS
2026-Q2 ★ 60% 60% 60% VRTX · REGN · ARGX · GILD · SRRK · VRDN · KRYS · CRNX · RVMD · ISRG AMGN · VRTX · ARGX · GILD · RVMD · ORKA · INSM · SRRK · NUVL · VRDN

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did Bellevue Group AG buy in 2026-Q2?

In its 2026-Q2 13F filing, Bellevue Group AG reported 148 equity positions worth $4.75B in aggregate; its largest disclosed positions were AMGN ($308.36M), VRTX ($287.42M), ARGX ($279.26M).

How large is Bellevue Group AG's portfolio?

Bellevue Group AG reported $4.75B of long equity holdings across 148 positions as of 2026-Q2. Top-10 holdings account for 42.9% of reported value.

What is Bellevue Group AG's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bellevue-group-ag/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →